Your browser doesn't support javascript.
loading
Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer.
Bian, S X; Kuban, D A; Levy, L B; Oh, J; Castle, K O; Pugh, T J; Choi, S; McGuire, S E; Nguyen, Q N; Frank, S J; Nguyen, P L; Lee, A K; Hoffman, K E.
Afiliação
  • Bian SX; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston; Baylor College of Medicine, Houston.
  • Kuban DA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Levy LB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Oh J; Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston.
  • Castle KO; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Pugh TJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Choi S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • McGuire SE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Nguyen QN; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Nguyen PL; Department of Radiation Oncology, Dana Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, USA.
  • Lee AK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Hoffman KE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston. Electronic address: khoffman1@mdanderson.org.
Ann Oncol ; 23(9): 2346-2352, 2012 Sep.
Article em En | MEDLINE | ID: mdl-22357249
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antagonistas de Androgênios / Neoplasias Hormônio-Dependentes / Antineoplásicos Idioma: En Ano de publicação: 2012 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antagonistas de Androgênios / Neoplasias Hormônio-Dependentes / Antineoplásicos Idioma: En Ano de publicação: 2012 Tipo de documento: Article